Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature.
Clicks: 228
ID: 79811
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
71.5
/100
228 views
182 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The human JAK2 gene is mainly targeted by two types of genetic lesions that play roles in the pathogenesis of hematologic malignancies: intragenic mutations and chromosomal translocations. Chromosomal translocations of JAK2 are typically associated with myeloid or lymphoid malignancies with an aggressive course and poor outcome. Here we report a t(9;22)(p24;q11.2) translocation, in a MDS patient and review results associated with BCR-JAK2 fusion reported in the literature.Reference Key |
kantarcioglu2015myelodysplasticinternational
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Kantarcioglu, Bulent;Kaygusuz-Atagunduz, Isik;Uzay, Ant;Toptas, Tayfur;Tuglular, Tulin Firatli;Bayik, Mahmut; |
Journal | international journal of hematology |
Year | 2015 |
DOI | 10.1007/s12185-015-1792-2 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.